1 of Wall Street’s Top Picks for Long-Term Investment and 2 That Fall Short

Wall Street Price Targets: Proceed with Caution

Analysts on Wall Street have issued optimistic price targets for the stocks discussed below, hinting at significant potential gains. However, it's wise to approach these projections with a critical eye, as institutional pressures can sometimes result in forecasts that are more hopeful than realistic.

Unlike major investment banks, StockStory is committed to offering unbiased insights to help you decide which companies truly deserve your attention. With that in mind, let’s examine one stock where Wall Street’s enthusiasm appears justified, and two others where analysts may be underestimating key risks.

Stocks to Consider Selling

Byrna (BYRN)

Analyst Price Target: $34.80 (suggesting a possible 181% increase)

Byrna (NASDAQ:BYRN) specializes in non-lethal self-defense products, equipping civilians with tools designed to incapacitate or deter attackers without causing fatal harm.

Key Concerns with BYRN

• Poor control over expenses has resulted in an operating margin of -0.1%, which lags behind industry standards.
• The company’s tendency to burn through cash raises doubts about its ability to deliver lasting value to shareholders.
• With dwindling cash reserves, Byrna may need to raise additional funds, potentially diluting existing shareholders’ stakes.

Currently, Byrna trades at $12.38 per share, reflecting a forward price-to-earnings ratio of 27.1.

Trupanion (TRUP)

Analyst Price Target: $46.25 (implying a 60.8% potential return)

Trupanion (NASDAQ:TRUP) was founded to help pet owners avoid the difficult decision of economic euthanasia by providing tailored medical insurance for cats and dogs, using a data-driven and vertically integrated approach.

Reasons for Caution with TRUP

• Book value per share has remained flat over the past five years, limiting the company’s ability to leverage its balance sheet for further investments.
• Negative return on equity indicates that management has struggled to generate profits while expanding the business.

Trupanion is currently priced at $28.77 per share, with a forward price-to-book ratio of 2.8.

Stock to Watch: A Potential Buy

Remitly (RELY)

Analyst Price Target: $21.50 (projecting a 24.5% upside)

Remitly (NASDAQ:RELY), which counts Amazon’s Jeff Bezos among its early backers, operates a digital platform that allows users to send money internationally with speed and security.

What Makes RELY Stand Out?

• The company’s active customer base has expanded at an annual rate of 29.2%, opening up opportunities for cross-selling if new products and features are introduced.
• Remitly’s earnings per share have surged by 108% annually over the past three years, outpacing revenue growth and signaling improved profitability.
• Free cash flow margin has increased by 34.7 percentage points in recent years, providing more capital for growth initiatives, share buybacks, or dividends.

With shares trading at $17.28, Remitly’s forward EV/EBITDA ratio stands at 9.6. Is this a good entry point?

Top Stocks for Any Market Environment

ALSO RECOMMENDED: Top 5 Momentum Stocks. The ideal time to invest in a standout company is when it’s gaining market attention. These aren’t just fundamentally strong businesses—each is currently experiencing significant momentum, combining robust financials with timely catalysts.

Discover which stocks our AI-driven platform is highlighting this week.

Our 2020 picks included now-household names like Nvidia (up 1,326% from June 2020 to June 2025) and lesser-known companies such as Kadant, which delivered a 351% five-year return.